GovChime
Notice ID: 7ad4d87b74bf45b280c42b1f75fe5053Award NoticeAwarded

6505--Buprenorphine/Naloxone Sublingual Tablets

Awarded on December 22, 2020. Full description on SAM.gov.

Awarded tounder 36E79721D0013 (source: SAM.gov award notice)• $28.2M

Overview

Posted
December 22, 2020
Notice type
Award Notice
NAICS
325412: Pharmaceutical Preparation Manufacturing
Agency
Department of Veterans Affairs

Notice details

Last updated
Dec 4, 2025
Award date
Dec 22, 2020
Award amount (SAM.gov award notice)
$28.2M

Identifiers

Solicitation number
36E79721R0001
Notice ID
7ad4d87b74bf45b280c42b1f75fe5053
Award number (PIID)
36E79721D0013

Description

PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79721R0001 for an unrestrictive procurement for Buprenorphine HCL/Naloxone HCL Sublingual Tablets for the Department of Veterans Affairs (VA), Department of Defense (DOD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s and DOD s respective Pharmaceutical Prime Vendor Programs. Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have a unique NDC number. Solicitation # 36E79721R0001 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about October 27, 2020, with a tentative closing date of November 10, 2020. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at the following URL: https://beta.sam.gov/. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check this URL for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Matthew Poulin. Questions can be emailed to: Matthew.Poulin@va.gov. The estimated annual requirements are as follows: ITEM DESCRIPTION SIZE (TABS PER BOTTLE) ESTIMATED ANNUAL REQUIREMENTS (BOTTLES) 1 BUPRENORPHINE HCL 2MG/NALOXONE HCL 0.5MG TAB,SUBLINGUAL 30 145,412 2 BUPRENORPHINE HCL 8MG/NALOXONE HCL 2MG TAB,SUBLINGUAL 30 275,699

Full description on SAM.gov

Award Overview

Award Number

36E79721D0013

Award Amount (SAM.gov award notice)

$28.2M

Award Date

Dec 22, 2020

Awardee

Awardee UEI

SJ9MSB1UXGL8

Awardee CAGE Code

84GK4

Original Solicitation

Notice ID: 7ad4d87b74bf45b280c42b1f75fe5053

Posted Date: Dec 22, 2020

Original Response Deadline: Not specified

More From This Vendor

Top 5 most recent

5
  • 36F79722D0205
    SPECGX LLC
    Department of Veterans AffairsNAICS 325412
    —Signed Nov 3, 2026
  • 36F79722D0205
    SPECGX LLC
    Department of Veterans AffairsNAICS 325412
    —Signed Oct 26, 2026
  • 36F79722D0205
    SPECGX LLC
    Department of Veterans AffairsNAICS 325412
    —Signed Oct 20, 2026
  • 36F79722D0205
    SPECGX LLC
    Department of Veterans AffairsNAICS 325412
    —Signed Oct 8, 2026
  • 36E79723D0016
    SPECGX LLC
    Department of Veterans AffairsNAICS 325412
    —Signed Sep 10, 2026

Contacts

Documents

No documents available.

Lifecycle

Solicitation:36E79721R0001
  1. Pre-Solicitation
  2. Solicitation
  3. Awarded

This opportunity has been awarded.

  1. Pre-SolicitationOct 2, 2020

    6505--Buprenorphine/Naloxone Sublingual Tablet

    Notice 901dbdcd8925444abcf5503170879fb8 on SAM.gov

  2. 3×
    SolicitationOct 22, 2020

    6505--Buprenorphine/Naloxone Sublingual Tablet

    Notice 0ee4085db1ea460c99d69d299fd3d63e on SAM.gov

  3. AwardedCurrentDec 22, 2020

    6505--Buprenorphine/Naloxone Sublingual Tablets

    Notice 7ad4d87b74bf45b280c42b1f75fe5053 on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline
88%
AwardedOpen
88%
Solicitation08/13/2026
PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79726R0032 for an unrestricted procurement for Lisinopril Tablets, for the Department of Veterans Affairs (VA) (inclusive of Consolidated Mail Order Pharmacies (CMOPs) and Option 2 State Veterans Homes (SVH)), Department of Defense (DoD) (inclusive of Tricare Mail Order Pharmacies (TMOPs)), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC). VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted item. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s and DOD s respective Pharmaceutical Prime Vendor Programs. Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have an NDC number that is unique to the offeror. The successful offeror/contractor's label with its unique NDC shall be the only label on the product. Contractors shall not affix their label over another label on the product. VA labels must be able to securely adhere on top of the successful offeror/contractor s label. All unit of use packaging identified in the Schedule of Supplies, (Line items 3, 4, 7, 8, 11, 12, 14, 18, 19, and 31 for 45 and 90 count bottles) shall contain a safety-cap capable of having the outer part of the cap deshelled and / or a convertible cap to produce a non-safety cap and a bottle with a minimum required size of 120cc volume. The safety cap must not exceed the diameter of the bottle. The bottle must have a cylindrical body and minimum of 5.75 circumference. The bottle must fit a label with a dimension of 5.25 x 2 . The 0.5 additional space is required to keep the bar code exposed and/or allow for the display of the expiration date and lot number. Solicitation # 36E79726R0032 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about September 3, 2026 with a tentative closing date of September 24, 2026 The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at sam.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check Contracting Opportunities at SAM.gov for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Youlanda Duggar. Questions can be e-mailed to Youlanda.Duggar@va.gov. Please see the Excel spreadsheet for estimated annual quantities.
87%
Pre-Solicitation09/24/2026
PRE-SOLICITATION NOTICE: The VA Enterprise Procurement Office intends to issue Request for Proposal (RFP) 36E79727R0007 for an unrestricted procurement for Sacubitril-Valsartan Tablets, for the Department of Veterans Affairs (VA) (inclusive of Consolidated Mail Order Pharmacies (CMOPs) and Option 2 State Veterans Homes (SVH)), Department of Defense (DoD) (inclusive of Tricare Mail Order Pharmacies (TMOPs)), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC). VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s and DOD s respective Pharmaceutical Prime Vendor Programs. One or more of the items under this acquisition is subject to the World Trade Organization Government Procurement Agreement and Free Trade Agreements. Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have an NDC number that is unique to the offeror. The successful offeror/contractor's label with its unique NDC shall be the only label on the product. Contractors shall not affix their label over another label on the product. VA labels must be able to securely adhere on top of the successful offeror/contractor s label. All unit of use packaging identified in the Schedule of Supplies, (60 & 180 count bottles) shall contain a safety-cap capable of having the outer part of the cap deshelled and / or a convertible cap to produce a non-safety cap and a bottle with a minimum required size of 120cc volume. The safety cap must not exceed the diameter of the bottle. The bottle must have a cylindrical body and minimum of 5.75 circumference. The bottle must fit a label with a dimension of 5.25 x 2 . The 0.5 additional space is required to keep the bar code exposed and/or allow for the display of the expiration date and lot number. Solicitation # 36E79727R0007 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about December 18, 2026, with a tentative closing date of January 7, 2027. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at SAM.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check Contracting Opportunities at SAM.gov for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is James Sullivan. Questions can be e-mailed to james.sullivan3@va.gov. The estimated annual requirements are as follows:
85%
Pre-Solicitation11/03/2026
Valsartan Tablets Solicitation SPE2D2-26-R-0011
74%
Solicitation07/23/2026

Additional Details

Solicitation Number

36E79721R0001

Archive Date

Feb 20, 2021

Office Address

HINES, IL, 60141